{
    "nct_id": "NCT03741673",
    "official_title": "A Phase III Trial of Pre-Operative Stereotactic Radiosurgery (SRS) Versus Post-Operative SRS for Brain Metastases",
    "inclusion_criteria": "* The primary lesion pre-operatively can have a maximum diameter of =< 4 cm for single fraction and =< 7 cm for multifraction therapy\n* Patients must be considered candidates for SRS within +/- 30 days of surgical resection as defined by either history and physical (H&P) or presentation at brain metastasis tumor board conference note\n* Patients must have a Karnofsky performance scores >= 70 or Eastern Cooperative Oncology Group (ECOG) >= 2 within 30 days of enrollment\n* Patients must agree to randomization as documented by signing the Institutional Review Board (IRB) approved consent form\n* No radiographic evidence of leptomeningeal disease on MD Anderson Cancer Center (MDACC) departmental radiology report or study neuro-radiologist review\n* Documented history of malignancy\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients who have received prior radiation therapy to the brain for any reason\n* The primary tumor is small-cell lung cancer, lymphoma, leukemia, or multiple myeloma\n* For females, if they are pregnant or breast-feeding (The exclusion is made because gadolinium may be teratogenic in pregnancy)",
    "miscellaneous_criteria": ""
}